Molina Healthcare (NYSE:MOH – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Sunday, Wall Street Zen reports.
Other research analysts also recently issued reports about the company. JPMorgan Chase & Co. boosted their target price on Molina Healthcare from $169.00 to $191.00 and gave the stock a “neutral” rating in a report on Monday, June 8th. Cantor Fitzgerald reiterated a “neutral” rating on shares of Molina Healthcare in a research report on Friday, September 4th. Zacks Research upgraded Molina Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, September 22nd. Wells Fargo & Company reduced their price objective on Molina Healthcare from $235.00 to $220.00 and set an “equal weight” rating on the stock in a research note on Tuesday, July 28th. Finally, Truist Financial decreased their target price on Molina Healthcare from $250.00 to $225.00 and set a “hold” rating on the stock in a report on Friday, July 24th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, Molina Healthcare currently has an average rating of “Hold” and an average price target of $202.44.
Read Our Latest Stock Analysis on MOH
Molina Healthcare Price Performance
Molina Healthcare (NYSE:MOH – Get Free Report) last released its quarterly earnings data on Wednesday, July 22nd. The company reported $1.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.12. The firm had revenue of $10.87 billion during the quarter, compared to analyst estimates of $10.83 billion. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.The business’s revenue for the quarter was down 4.8% compared to the same quarter last year. During the same period in the prior year, the company posted $5.48 earnings per share. On average, sell-side analysts forecast that Molina Healthcare will post 5.29 EPS for the current fiscal year.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the stock. BlackRock Inc. bought a new position in Molina Healthcare in the 2nd quarter valued at $1,503,052,000. Dimensional Fund Advisors LP raised its position in shares of Molina Healthcare by 23.7% during the first quarter. Dimensional Fund Advisors LP now owns 1,394,882 shares of the company’s stock worth $185,929,000 after acquiring an additional 267,121 shares during the last quarter. Wellington Management Group LLP raised its position in shares of Molina Healthcare by 11.9% during the second quarter. Wellington Management Group LLP now owns 1,267,207 shares of the company’s stock worth $289,810,000 after acquiring an additional 135,247 shares during the last quarter. 8 Knots Management LLC bought a new stake in shares of Molina Healthcare during the fourth quarter worth $198,942,000. Finally, Capital Research Global Investors lifted its stake in shares of Molina Healthcare by 0.4% during the fourth quarter. Capital Research Global Investors now owns 795,909 shares of the company’s stock valued at $138,122,000 after acquiring an additional 3,123 shares during the period. Institutional investors own 98.50% of the company’s stock.
Molina Healthcare Company Profile
Molina Healthcare, Inc is a managed-care company that provides health insurance and related healthcare services primarily to individuals and families who receive coverage through government-sponsored programs. Its main lines of business include Medicaid, Medicare, and health plans offered through government marketplaces.
The company works with state and federal agencies, healthcare providers, and community organizations to coordinate care for members, including low-income adults and children, seniors, and people with disabilities or complex medical needs.
Featured Stories
- Five stocks we like better than Molina Healthcare
- NVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can Run
- A Manufacturing Surprise Could Be a Big Win for These 2 Companies
- What a $1 Billion Chip Deal Says About Amazon’s AI Ambitions
- 3 Stocks Benefiting From AI Demand Just Announced Major Buybacks
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
